Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 21:17:1184-1194.
doi: 10.1016/j.csbj.2019.08.003. eCollection 2019.

Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools

Affiliations

Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools

Carmen Mei et al. Comput Struct Biotechnol J. .

Abstract

Purpose: Aluminum-based adjuvants including aluminum phosphate (AlPO4) are commonly used in many human vaccines to enhance immune response. The interaction between the antigen and adjuvant, including the physical adsorption of antigen, may play a role in vaccine immunogenicity and is a useful marker of vaccine product quality and consistency. Thus, it is important to study the physicochemical properties of AlPO4, such as particle size and chemical composition. Control of the vaccine adjuvant throughout the manufacturing process, including raw materials and the intermediate and final product stages, can be effectively achieved through monitoring of such key product attributes to help ensure product quality.

Methods: This study focuses on the compositional analysis of AlPO4 adjuvant at the intermediate and final manufacturing stages using the off-line methods Fourier-Transform Infrared (FTIR) and Raman spectroscopy, X-ray Photoelectron Spectroscopy (XPS), and the in-line method Attenuated Total Reflectance (ATR). Particle size distribution of AlPO4 was measured off-line using Laser diffraction (LD) and in-line using Focused Beam Reflectance Measurement (FBRM®).

Results: There was no observable difference in size distribution between the intermediate and final stage AlPO4 by off-line and in-line analysis, in both small- or large-scale production samples. Consistent peak shifts were observed in off-line and in-line infrared (IR) spectroscopy as well as off-line XPS for both small- and large-scale AlPO4 manufacturing runs. Additionally, IR spectroscopy and FBRM® for size distribution were used as in-line process analytical technology (PAT) to monitor reaction progress in real-time during small-scale AlPO4 manufacturing from raw materials. The small-scale adsorption process of a model protein antigen (Tetanus toxoid) to AlPO4 adjuvant was also monitored by in-line ReactIR probe.

Conclusion: This study demonstrated that in-line PAT can be used to monitor particle size and chemical composition for the various stages of adjuvant manufacturing from raw materials through intermediate to final adjuvant product stage. Similar approaches can be utilized to help assess lot-to-lot consistency during adjuvant manufacturing and vaccine product development. Moreover, the use of in-line PAT is highly conductive to advanced manufacturing strategies such as real-time product release testing and automated processes of the future.

Keywords: Aluminum phosphate adjuvant (AlPO4); Focused beam reflectance measurement (FBRM®); Fourier transform infrared spectroscopy (FTIR); Laser diffraction (LD); Particle size distribution; Process analytical technology (PAT); Raman spectroscopy; X-ray photoelectron spectroscopy (XPS).

PubMed Disclaimer

Conflict of interest statement

Carmen Mei, Sasmit Deshmukh, Bruce Carpick, Matthew Balmer, Daniel Chapman, Nicole Lazaris, Liliana Sampaleanu, and Marina Kirkitadze are employees of Sanofi Pasteur. Jim Cronin, Shuxin Cong, Ulrich Schacht, and Katherine Drolet-Vives, Moriam Ore and Sylvie Morin have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Figures

Unlabelled Image
Graphical abstract
Fig. 1
Fig. 1
(a) Particle size distribution profiles of intermediate (green trace) and final (red trace) AlPO4 measured by LD; (b) FTIR and (c) Raman spectra of intermediate (green trace) and final (red trace) AlPO4 manufactured at large scale.
Fig. 2
Fig. 2
High resolution XPS spectra collected with the 15° take-off angle for Al 2p, P 2p, and O 1 s of intermediate (blue trace) and final (black trace) AlPO4 sample. Smooth curves represent the fitting. The horizontal lines on the graph represent the baseline used for fitting.
Fig. 3
Fig. 3
(a) AlPO4 precipitation reaction monitoring in real-time (b) Overlay of four AlPO4 intermediate lots size distribution profiles by LD (orange, dotted) and FBRM® (blue, solid); each lot was prepared by mixing AlCl3 and Na3PO4 raw materials in the EasyMax reactor (c) The size distribution of manufacturing scale AlPO4 by LD, intermediate and final (dotted), and by FBRM®, intermediate and final (solid).
Fig. 4
Fig. 4
(a) The inline IR spectral overlay of AlCl3 (red trace) and Na3PO4 (blue trace); (b) Inline IR monitoring of AlPO4 adjuvant formation during the small-scale precipitation reaction. The normalized IR peak height corresponding to AlCl3, AlPO4 transient intermediate are represented by the solid gray, solid blue, and solid red traces respectively. The dotted green trace represents the volume of Na3PO4 (in mL) added.
Fig. 5
Fig. 5
IR Spectra of (a) intermediate and (b) final AlPO4 (small-scale) using inline analysis; (c) IR Spectra of intermediate (red, magenta, and purple with a broad plateau) and final (green, blue, and pink with a narrow plateau) stage AlPO4 (large-scale) using inline analysis.
Fig. 5
Fig. 5
IR Spectra of (a) intermediate and (b) final AlPO4 (small-scale) using inline analysis; (c) IR Spectra of intermediate (red, magenta, and purple with a broad plateau) and final (green, blue, and pink with a narrow plateau) stage AlPO4 (large-scale) using inline analysis.
Fig. 6
Fig. 6
IR spectral overlay during inline monitoring of Tetanus Toxoid adsorption to final AlPO4 adjuvant. Red trace represents Tetanus Toxoid IR spectrum at the beginning of adsorption reaction. Amide II peak decreases during adsorption (downward arrow), while Amide I peak becomes more prominent (upward arrow), which is consistent with FTIR spectrum of Tetanus Toxoid reported previously [5].

References

    1. Hem S.L., Hogenesch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines. 2007;6(5):685–698. - PubMed
    1. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev. 1998;32(3):155–172. - PubMed
    1. HogenEsch H. Mechanism of immunopotentiation and safety to aluminum adjuvants. Front Immunol. 2013;3:1–13. article 406. [eCollection 2012] - PMC - PubMed
    1. Redman T., O'Grady D. American Institute of Chemical Engineers; 2017. Improve products and processes with in-line particle analysis; pp. 47–55.
    1. Kalbfleisch K., Deshmukh S., Mei C., Ore M., Williams W., Durowoju I. Identity, structure and compositional analysis of adjuvanted vaccines. Comput Struct Biotechnol J. 2019;17:14–20. - PMC - PubMed